English to Russian Medical Medical: Pharmaceuticals

Specify that dosing will be held for neutropenia or thrombocytopenia lasting 10 days rather than 7 days, and for thrombocytopenia associated with significant bleeding.
To enhance study drug efficacy and avoid disease rebound as long as possible.
Prolonging the time to withholding study drug delays inhibition of BTK signaling and potential disease rebound.